Anjali K Pandya
Overview
Explore the profile of Anjali K Pandya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anjani Q, Pandya A, Demartis S, Dominguez-Robles J, Moreno-Castellanos N, Li H, et al.
Int J Pharm
. 2023 Sep;
646:123446.
PMID: 37751787
Methicillin-resistant Staphylococcus aureus (MRSA) is a prevailing bacterial pathogen linked to superficial skin and soft tissue infections (SSTIs). Rifampicin (RIF), a potent antibiotic against systemic and localised staphylococcal infections, faces...
2.
Pandya A, Vora L, Umeyor C, Surve D, Patel A, Biswas S, et al.
Adv Drug Deliv Rev
. 2023 Jul;
200:115003.
PMID: 37422267
Polymeric in situ forming depots have emerged as highly promising drug delivery systems for long-acting applications. Their effectiveness is attributed to essential characteristics such as biocompatibility, biodegradability, and the ability...
3.
Chavda V, Vora L, Pandya A, Patravale V
Drug Discov Today
. 2021 Jul;
26(11):2619-2636.
PMID: 34332100
Unlike conventional Coronavirus 2019 (COVID-19) vaccines, intranasal vaccines display a superior advantage because the nasal mucosa is often the initial site of infection. Preclinical and clinical studies concerning intranasal immunization...
4.
Pandya A, Patravale V
Drug Discov Today
. 2021 Mar;
26(6):1510-1520.
PMID: 33684525
Proteins and peptides are amongst the most sought-after biomolecules because of their exceptional potential to cater to a vast range of diseases. Although widely studied and researched, the oral delivery...